MRNA
📉 Moderna’s stock has experienced a significant 64% drop in the last 12 months.
💉 Its business heavily relied on selling COVID-19 vaccines, which is now a declining market.
⚠️ This exemplifies the risks of investing in companies with limited product diversification within ETFs.
@InvertirdesdeCero:
“As an example of companies in which you are invested when you buy an S&P 500 ETF, we find companies like the pharmaceutical company, Moderna, which has suffered a 64% drop in the stock market in the last 12 months, since its business was based on selling only vaccines against COVID, something that is obviously a declining business.”
Watch the exact part of the video where @InvertirdesdeCero talks about Moderna here:
View the video on YouTube.
Read more articles by the world’s top 100 analysts on Moderna (MRNA) at the following link. MRNA stock.
